Skip to Content

'
Steven J. Frank, MD

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Assistant Professor, Department of Radiation Oncology, Radiology, Baylor College of Medicine, Houston, TX

Education & Training

Degree-Granting Education

2000 Emory University School of Medicine, Atlanta, GA, MD, General Science
1995 U.S. Naval Nuclear Propulsion Program, Washington, DC, Nuclear Engineer, Nuclear Engineering
1991 University of Pennsylvania, Philadelphia, PA, BA, History

Postgraduate Training

7/2004-8/2004 Clinical Fellowship, Prostate Brachytherapy, Seattle Prostate Institute, Seattle, WA
7/2001-7/2005 Clinical Residency, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Dr. James D. Cox
7/2000-7/2001 Research Internship, Internal Medicine, Emory University School of Medicine, Atlanta, GA
7/1991-7/1996 Nuclear Engineer, Nuclear Engineering, United States Naval Nuclear Propulsion Program, Washington, DC

Board Certifications

7/2006 American Board of Radiology

Experience/Service

Administrative Appointments/Responsibilities

Committee Chair, Radiation Oncology Mentoring Program, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010-present
Committee Chair, RadOnc 2010, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009-present

Other Appointments/Responsibilities

Expert Panel Member, Texas Medical Board, Austin, TX, 2009-present
Member, Prostate Cancer Appropriateness Committee, American College of Radiology, Reston, VA, 2009-present

Military or Other Governmental Service

Lieutenant, U. S. Navy, 5/1991-5/1996

Institutional Committee Activities

Committee Member, Proton Therapy Conference, 2011-present
Member, Clinical and Research Informatics Committee, 3/2010-present
Member QA Committee - Head and Neck and Prostate Brachytherapy, MD Anderson Physicians Network, 3/2009-present

Honors and Awards

2011-2012 Best Doctors in America
2010-2011 Best Doctors in America
2009-2010 Best Doctors in America
2008-present Expert Panel Member, Texas Medical Board
2008-present Radiation Oncology Board Certification Exam Writer, American Board of Radiology (ABR)
2008-2011 2008 Young Investigator Award, Prostate Cancer Foundation
2008 Chair, U.T. M.D. Anderson Cancer Center Institutional Grand Rounds
2005 3rd International IMRT Treatment Planning Conference Travel Award
2004 American College of Radiology Council Steering Committee
2004 ASTRO Radiation Physics Committee
2004 Seattle Prostate Institute Brachytherapy Fellowship
2003-2005 Association of Residents in Radiation Oncology Executive Board
2003-2005 Residency Review Committee (RRC) for Radiation Oncology
2003 Texas Radiological Society Outstanding Resident Presentation Award
2002 Berlex Oncology Foundation Award
2002 Fletcher Society Resident Research Award
2002 RSNA Research Trainee Award

Selected Publications

Peer-Reviewed Original Research Articles
1. Ciezki JP, Hsu IC, Abdel-Wahab M, Arterbery VE, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G. American College of Radiology Appropriateness Criteria(®) - Locally Advanced (High-risk) Prostate Cancer. Clin Oncol (R Coll Radiol). e-Pub 8/2011.
2. Frank SJ, Levy LB, Vulpen M, Crook J, Sylvester J, Grimm P, Pugh TJ, Swanson DA. Outcomes Following Prostate Brachytherapy are Even Better Than Predicted. Cancer, 7/2011. e-Pub 7/2011.
3. Skinner HD, Garden AS, Rosenthal DI, Ang KK, Morrison WH, Esmaeli B, Pinnix CC, Frank SJ. Outcomes of malignant tumors of the lacrimal apparatus: the University of Texas M. D. Anderson Cancer Center experience. Cancer 117(12):2801-10, 6/2011. e-Pub 1/2011. PMID: 21225861.
4. Frank SJ, Arterbery VE, Hsu IC, Abdel-Wahab M, Ciezki JP, Hahn NM, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G. American College of Radiology Appropriateness Criteria Permanent Source Brachytherapy for Prostate Cancer. Brachytherapy. e-Pub 4/2011. PMID: 21497562.
5. Kuban DA, Levy LB, Cheung MR, Lee AK, Choi S, Frank S, Pollack A. Long-term Failure Patterns and Survival in a Randomized Dose-Escalation Trial for Prostate Cancer. Who Dies of Disease? Int J Radiat Oncol Biol Phys 79(5):1310-7, 4/2011. e-Pub 5/2010. PMID: 20493642.
6. Rossi CJ, Joe Hsu IC, Abdel-Wahab M, Arterbery VE, Ciezki JP, Frank SJ, Hahn NM, Moran BJ, Rosenthal SA, Merrick G. ACR Appropriateness Criteria® Postradical Prostatectomy Irradiation in Prostate Cancer. Am J Clin Oncol 34(1):92-98, 2/2011. PMID: 21270599.
7. Vassiliev ON, Kudchadker RJ, Swanson DA, Bruno TL, van Vulpen M, Frank SJ. Displacement of periurethral stranded seeds and its dosimetric consequences in prostate brachytherapy. Brachytherapy. e-Pub 2/2011. PMID: 21306959.
8. Shirvani SM, Kudchadker RJ, Bruno TL, Likhacheva A, Swanson DA, Frank SJ. Impact Of Urinary Catheterization On Dosimetry After Prostate Implant Brachytherapy With Palladium-103 Or Iodine-125. Brachytherapy. e-Pub 2/2011. PMID: 21296031.
9. Hinnen KA, Monninkhof EM, Battermann JJ, van Roermund JG, Frank SJ, van Vulpen M. Prostate Specific Antigen Bounce Is Related to Overall Survival in Prostate Brachytherapy. Int J Radiat Oncol Biol Phys. e-Pub 2/2011. PMID: 21300477.
10. Savar A, Oellers P, Myers J, Prieto VG, Torres-Cabala C, Frank SJ, Ivan D, Esmaeli B. Positive Sentinel Node in Sebaceous Carcinoma of the Eyelid. Ophthal Plast Reconstr Surg 27(1):e4-6, Jan-Feb, 1/2011. e-Pub 10/2010. PMID: 20940661.
11. Sharp HJ, Swanson DA, Patel H, Gorbatiy V, Frenzel JC, Frank SJ. Subacute penile numbness after brachytherapy for prostate cancer. Brachytherapy 10(1):64-7, Jan-Feb, 1/2011. e-Pub 8/2010. PMID: 20685173.
12. Frank SJ, Tailor RC, Kudchadker RJ, Martirosyan KS, Stafford RJ, Elliott AM, Swanson DA, Sing D, Choi J, Mourtada F, Ibbott GS. Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy. Med Dosim 36(2):200-5, 2011. e-Pub 5/2010. PMID: 20537886.
13. Frank SJ, Rosenthal DI, Petsuksiri J, Ang KK, Morrison WH, Weber RS, Glisson BS, Chao KS, Schwartz DL, Chronowski GM, El-Naggar AK, Garden AS. Intensity-Modulated Radiotherapy for Cervical Node Squamous Cell Carcinoma Metastases from Unknown Head-and-Neck Primary Site: M. D. Anderson Cancer Center Outcomes and Patterns of Failure. Int J Radiat Oncol Biol Phys 78(4):1005-10, 11/2010. e-Pub 3/2010. PMID: 20207504.
14. Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman SM, Schwartz DL. Prospective Imaging Assessment of Mortality Risk After Head-and-Neck Radiotherapy. Int J Radiat Oncol Biol Phys 78(3):667-74, 11/2010. e-Pub 2/2010. PMCID: PMC3072063.
15. Roeloffzen EM, Hinnen KA, Battermann JJ, Monninkhof EM, van Roermund JG, van Gellekom MP, Frank SJ, van Vulpen M. The Impact of Acute Urinary Retention After Iodine-125 Prostate Brachytherapy on Health-Related Quality of Life. Int J Radiat Oncol Biol Phys 77(5):1322-8, 8/2010. e-Pub 11/2009. PMID: 19939578.
16. Rosenthal DI, Fuller CD, Barker JL, Mason B, Garcia JA, Lewin JS, Holsinger FC, Stasney CR, Frank SJ, Schwartz DL, Morrison WH, Garden AS, Ang KK. Simple Carotid-Sparing Intensity-Modulated Radiotherapy Technique and Preliminary Experience for T1-2 Glottic Cancer. Int J Radiat Oncol Biol Phys 77(2):455-61, 6/2010. e-Pub 8/2009. PMID: 19679406.
17. Frank SJ, Selek U. Proton Beam Radiation Therapy for Head and Neck Malignancies. Curr Oncol Rep 12(3):202-7, 5/2010. PMID: 20425080.
18. Frank SJ, Kudchadker RJ, Kuban DA, De Crevoisier R, Lee AK, Cheung RM, Choi S, Tucker SL, Dong L. A Volumetric Trend Analysis of the Prostate and Seminal Vesicles during a Course of Intensity-Modulated Radiation Therapy. Am J Clin Oncol 33(2):173-5, 4/2010. PMID: 20010077.
19. Hinnen KA, Battermann JJ, van Roermund JG, Moerland MA, Jürgenliemk-Schulz IM, Frank SJ, van Vulpen M. Long-Term Biochemical and Survival Outcome of 921 Patients Treated with I-125 Permanent Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 76(5):1433-8, 4/2010. e-Pub 6/2009. PMID: 19540075.
20. Roeloffzen EM, Lips IM, van Gellekom MP, van Roermund J, Frank SJ, Battermann JJ, van Vulpen M. Health-Related Quality of Life up to Six Years After (125)I Brachytherapy for early-stage Prostate Cancer. Int J Radiat Oncol Biol Phys 76(4):1054-60, 3/2010. e-Pub 1/2010. PMID: 20097486.
21. Anderson JF, Swanson DA, Levy LB, Kuban DA, Lee AK, Kudchadker R, Phan J, Bruno T, Frank SJ. Urinary Side Effects and Complications After Permanent Prostate Brachytherapy: The MD Anderson Cancer Center Experience. Urology 74(3):601-5, 9/2009. e-Pub 7/2009. PMID: 19589580.
22. Peterson S, Polf J, Ciangaru G, Frank SJ, Bues M, Smith A. Variations in Proton Scanned Beam Dose Delivery Due to Uncertainties in Magnetic Beam Steering. Med Phys 38(8):3693-3702, 8/2009. PMID: 19746802.
23. Phan J, Swanson DA, Levy LB, Kudchadker RJ, Bruno TL, Frank SJ. Late Rectal Complications after prostate brachytherapy for localized prostate cancer: Incidence and Management. Cancer 115(9):1827-1839, 5/2009. PMID: 19248043.
24. Martirosyan KS, Stafford RJ, Elliott AM, and Frank SJ. PMMA/SWCNTs Composites for Prostate Brachytherapy MRI Contrast Agent Markers. Technical Proceedings of the 2009 NSTI Nanotechnology Conference and Expo 2:44-47, 5/2009.
25. Moeller B, Rana V, Cannon B, Williams M, Sturgis E, Ginsberg L, Macapinlac H, Lee J, Ang KK, Chao KSC, Chronowski G, Frank SJ, Morrison W, Rosenthal D, Weber R, Garden A, Lippman S, Schwartz D. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol 27(15):2509-2515, 3/2009. e-Pub 3/2009. PMID: 19332725.
26. Frank SJ, Levy LB, Kuban DA, Lee AK, Kudchadker RJ, Bruno TL, van Vulpen M, Swanson DA. Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy. J Urol 181(4). e-Pub 2/2009. PMID: 19233434.
27. Hsu A, Frank SJ, Ballo MT, Garden AS, Morrison WH, Rosenthal DI, Hatef E, Esmaeli B. Post-operative Adjuvant External-beam Radiation Therapy for Cancers of the Eyelid and Conjunctiva. Ophthal Plast Reconstr Surg 24(6):444-449, Nov-Dec, 11/2008. PMID: 19033839.
28. Kudchadker RJ, Swanson DA, Kuban DA, Lee AK, Bruno TL, Frank SJ. Is a Loose-Seed Nomogram Still Valid for Prostate Brachytherapy in a Stranded-Seed Era? Int J Radiat Oncol Biol Phys 72(2):623-7, 10/2008.
29. McGuire SE, Frank SJ*, Eifel PJ (*corresponding author). Treatment of recurrent vaginal melanoma with external beam radiation therapy and palladium-103 brachytherapy. Brachytherapy 7(4):359-63, Oct-Dec, 10/2008. e-Pub 9/2008. PMID: 18778972.
30. Frank SJ, Dong L, Kudchadker RJ, De Crevoisier R, Lee AK, Cheung R, Choi S, O'Daniel J, Tucker SL, Wang H, Kuban DA. Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys 71(3):813-20, 7/2008. e-Pub 1/2008. PMID: 18207664.
31. Frank SJ, Stafford RJ, Bankson JA, Li C, Swanson DA, Kudchadker RJ, Martirosyan KS. A Novel MRI Marker for Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 71(1):5-8, 5/2008. PMID: 18406882.
32. Petsuksiri J, Frank SJ, Garden AS, Ang KK, Morrison WH, Chao KS, Rosenthal DI, Schwartz DL, Ahamad A, Esmaeli B (*corresponding author). Outcomes after radiotherapy for squamous cell carcinoma of the eyelid. Cancer 112(1):111-8, 1/2008. e-Pub 10/2007. PMID: 17963262.
33. Chao KS, Bhide S, Chen H, Asper J, Bush S, Franklin G, Kavadi V, Liengswangwong V, Gordon W, Raben A, Strasser J, Kaproswki C, Frank SJ, Chronowski G, Ahamad A, Malyapa R, Zhang L, Dong L. Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach. Int J Radiat Oncol Biol Phys 68(5):1512-21, 8/2007. PMID: 17674982.
34. Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. The Journal of Urology 177(6):2151-6, 6/2007. PMID: 17509305.
35. Frank SJ, Deavers MT, Jhingran A, Bodurka DC, Eifel PJ. Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure. Gynecol Oncol 105(2):470-4, 5/2007. PMID: 17292459.
36. Cheung MR, Tucker SL, Dong L, de Crevoisier R, Lee AK, Frank S, Kudchadker RJ, Thames H, Mohan R, Kuban D. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 67:1059-65, 3/2007. PMID: 17241755.
37. Frank SJ, Grimm PD, Sylvester JE, Merrick GS, Davis BJ, Zietman A, Moran BJ, Beyer DC, Roach M, Clarke DH, Stock RG, Robert Lee W, Michalski JM, Wallner KE, Hurwitz M, Potters L, Kuban DA, Prestidge BR, Vera R, Hathaway S, Blasko JC. Interstitial Implant Alone or in Combination with External Beam Radiation Therapy for Intermediate-Risk Prostate Cancer: A Survey of Practice Patterns in the United States. Brachytherapy 6(1):2-8, Jan-Mar, 2007. PMID: 17284379.
38. Patel S, Jagsi R, Wilson J, Frank S, Thakkar VV, Hansen EK. Results of the 2004 Association of Residents in Radiation Oncology (ARRO) Survey. Int J Radiat Oncol Biol Phys 66(4):1199-203, 11/2006. PMID: 16979833.
39. Lee AK, Frank SJ. Update on Radiation Therapy in Prostate Cancer. Hematol Oncol Clin North Am 20(4):857-878, 8/2006. PMID: 16861119.
40. Frank SJ, Chao KS, Schwartz DL, Weber RS, Apisarnthanarax S, Macapinlac HA. Technology Insight: PET and PET/CT in Head and Neck Tumor Staging and Radiation Therapy Planning. Nat Clin Pract Oncol 2(10):526-533, 10/2005. PMID: 16205772.
41. Frank SJ, Jhingran A, Levenback C, Eifel PJ. Definitive Treatment of Invasive Squamous Cell Carcinoma of the Vagina with Radiation Therapy. Int J Radiat Oncol Biol Phys 62(1):138-147, 5/2005. PMID: 15850914.
42. Callaghan EB, Padgett AV, Frank SJ. Self-Referral: What Residents Need to Know? J Am Coll Radiol 2(5):452454, 5/2005. PMID: 17411855.
43. Jagsi R, Buck DA, Singh AK, Engleman M, Thakkar V, Frank SJ, Flynn D. Results of the 2003 Association of Residents in Radiation Oncology (ARRO)( Surveys of Residents and Chief Residents in the United States. Int J Radiat Oncol Biol Phys 61(3):642-648, 3/2005. PMID: 15708241.
44. Frank SJ, McNeese MD, Strom EA, Perkins G, Salehpour M, Schechter N, Buchholz TA. Advances in Radiation Treatments of Breast Cancer. Clin Breast Cancer 4(6):401-406, 2/2004. PMID: 15023240.
45. Brooks C, Starkschall G, Famiglietti R, Cox J, Frank S, Komaki R, Liao Z, Stevens C, Forster K. Heterogeneous Planning for Homogeneous Protocols. Medical Dosimetry 29(2):80-84, 2004. PMID: 15191752.
46. Frank SJ, Forster KM, Stevens CW, Cox JD, Komaki R, Liao Z, Tucker S, Wang X, Steadham RE, Brooks C, Starkschall G. Treatment Planning for lung cancer: traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription. Int J Radiat Oncol Biol Phys 56(5):1308-1318, 8/2003. PMID: 12873675.
47. Frank SJ, Curley MD, Ryder SJ. A Biomedical Review of the U. S. Navy Submarine Escape System: 1996; Naval Submarine Medical Research Laboratory. NSMRL Report, 5/1997.

Invited Articles
1. Pugh TJ, Frank SJ. Quality Of Life Issues In The Radiotherapeutic Management Of Localized Prostate Cancer. Radiation Medicine Rounds 2(1), 4/2011.

Editorials
1. Frank SJ, Yang T, Chao KSC. Role of PET-CT Fusion in Head and Neck Cancer. Oncology 2(19):246-249, 2005.
2. Frank SJ, Buchholz TA. Diminished Survival in Patients with Inner Versus Outer Quadrant Breast Cancers. Women's Oncology Review 3:157-158, 2003.

Abstracts
1. Melhus CS, Mourtada F, Mikell JK, Frank SJ, Rivard MJ. Dosimetric Influence of Brachytherapy Seed Spacers. Brachytherapy 10(1, Suppl):S94 - S95 (#PD71), 5/2011.
2. Frank SJ, Munsell MF, Pugh TJ, Kudchadker RJ, Bruno TL, Kuban DA, Lee AK, Choi S, Nguyen QN, Swanson DA. Long-Term Outcomes, Quality of Life, and Patient-Reported Satisfaction Following Prostate Brachytherapy: The M.D. Anderson Cancer Center Experience. Brachytherapy 10(1, Suppl):S16-S17 (#OR2), 5/2011.
3. Rosenthal DI, Gunn GB, Mendoza TR, Garden AS, Beadle BM, Morrison WH, Wang XS, Frank SJ, Weber RS, Ang KK, Cleeland CS. Long-term symptom burden after radiation treatment for oropharynx cancer: A comparison of 3D and IMRT techniques. J Clin Oncol 29(15S):369s (#5539), 5/2011.
4. Gunn GB, Mendoza TR, Garden AS, Wang XS, Morrison WH, Frank SJ, Hanna EY, Lu C, Beadle BM, Ang KK,Cleeland CS, Rosenthal DI. Patient-reported fatigue in head and neck cancer survivors. J Clin Oncol 29(15S):365s (#5523), 5/2011.
5. Pugh TJ, Frank SJ, Kudchadker R, Swanson DA, Davis JW. Prostate MRI in Men With Intermediate-Risk Prostate Cancer: Implications for Prostate Brachytherapy Monotherapy. Brachytherapy 10(1, Suppl):S30 (#OR34), 5/2011.
6. Papadimitrakopoulou V, Heymach J, Frank SJ, Myers J, Lin H, Tran HT, Chen C, Hirsch FR, Langmuir PB, Vasselli JR, Lippman SM, Raben D. Updated clinical and biomarker results from a phase I study of vandetanib with radiation therapy (RT) with or without cisplatin in locally advanced head and neck squamous cell carcinoma (HNSCC). J Clin Oncol 29(15S):362s (#5510), 5/2011.
7. Skinner HD, Sturgis EM, Klopp AH, Ang KK, Rosenthal DI, Garden AS, Morrison WH, Gunn GB, Frank SJ, Beadle BM. Characteristics and Clinical Outcomes of Patients with Multiple Potentially HPV-Related Malignancies. International Journal of Radiation Oncology, Biology, Physics 78(3, Suppl):S441-S442, 11/2010.
8. Morikawa LK, Kudchadker R, Kanke J, Oyervides M, Frank SJ, Lee AK, Hoffman K, Choi S, Nguyen Q, Kuban D. Endorectal Balloon in Post-operative Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics 78(3, Suppl):S395, 11/2010.
9. Mendoza TR, Gunn GB, Wang XS, Frank SJ, Beadle BM, Shah SH, Lu C, Hanna EY, Cleeland CS, Rosenthal DI. Impact of Symptom Burden on Survival in Patients With Head and Neck Cancer Treated With Definitive Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics 78(3, Suppl):S470-S471, 11/2010.
10. Kim MM, Hoffman KE, Levy LB, Master P, Frank SJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Improvement in Prostate Cancer Outcomes Over Time: A Twenty-Year Analysis. International Journal of Radiation Oncology, Biology, Physics 78(3, Suppl):S191-S192, 11/2010.
11. Albert JM, Zhang M, Bruno TL, Kudchadker RJ, Swanson DA, Frank SJ. MRI-Based Treatment Planning for Prostate Brachytherapy. International Journal of Radiation Oncology, Biology, Physics 78(3, Suppl):S372-S373, 11/2010.
12. Zhang M, Munsell MF, Swanson DA, Kudchadker RJ, Albert JM, Urbauer DL, Duban DA, Bruno TL, Frank SJ. Patients Can Expect Long-Term Satisfaction After Prostate Brachytherapy. International Journal of Radiation Oncology, Biology, Physics 78(3, Suppl):S367, 11/2010.
13. Kuban DA, Nogueras-Gonzales GM, Hamblin L, Lee AK, Choi S, Frank SJ, Nguyen QN, Hoffman KE, McGuire SE, Munsell MF. Preliminary Report of a Randomized Dose Escalation Trial for Prostate Cancer using Hypofractionation. International Journal of Radiation Oncology, Biology, Physics 78(3, Suppl):S58-S59, 11/2010.
14. Frank SJ, Levy LB, van Vulpen M, Crook J, Sylvester J, Grimm P, Swanson DA. Prostate Cancer Outcomes Following Brachytherapy Are Superior To Those Predicted By the Prostogram. International Journal of Radiation Oncology, Biology, Physics 78(3, Suppl):S148, 11/2010.
15. Fisher CM, Troncoso P, Swanson DA, Munsell MF, Kuban DA, Lee AK, Choi S, Nguyen QN, Frank SJ. Prostate Cancer-Specific Survival and Time to Recurrence Outcomes for Men Treated With Radical Prostatectomy, Intensity Modulated Radiation Therapy, or Brachytherapy at M.D. Anderson Cancer Center. International Journal of Radiation Oncology, Biology, Physics 78(3, Suppl):S147-S148, 11/2010.
16. McGuire SE, Levy LB, Settle SH, Choi S, Nguyen Q, Hoffman K, Frank SJ, Lee AK, Kuban D. PSA Response to Neoadjuvant Androgen Suppression Therapy Prior to High Dose Radiotherapy Predicts Survival in Clinically Localized High Risk Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics 78(3, Suppl):S124-S125, 11/2010.
17. Nguyen Q, Levy LB, Lee AK, Choi S, Frank SJ, HOffman K, McGuire S, Kuban DA. Risk Factors Predicting Failure and Prostate Cancer Mortality in High Risk Prostate Cancer Patients Treated with Definitive External Beam Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics 78(3, Suppl):S125, 11/2010.
18. Gunn GB, Garcia SM, Beadle BM, Hanna EY, William WN, Garden AS, Morrison WH, Frank SJ, Ang KK, Rosenthal DI. Skin Culture and Treatment Results in Head and Neck Cancer Patients With Severe Radiation Dermatitis and Potential Suprainfection. International Journal of Radiation Oncology, Biology, Physics 78(3, Suppl):S175, 11/2010.
19. Frank SJ, Register S, Levy LB, Kudchadker R, Bruno TL, Swanson DA. An MRI Dose Response Analysis for Urinary Morbidity Following Prostate Brachytherapy Monotherapy in a Phase II Prospective Trial. Brachytherapy 9(2, S1):S42, 4/2010.
20. Choi S, Johnson JL, de Crevoisier R, Lee AK, Dong L, Frank SJ, Nguyen Q, Kuban DA. Comparison of Alignment Using Transabdominal Ultrasound Versus Computed Tomography for Prostate Cancer Patients Treated with Intensity Modulated Radiation Therapy and Androgen Deprivation Therapy. Oncology 24(4, S3):53, 4/2010.
21. Fisher CM, Troncoso P, Kuban DA, Munsell MF, Yeh S, Lee AK, Swanson DA, Frank SJ. Do African American and White Men Have Differences in Their Rate of Pathological Upgrading? An MD Anderson Cohort Study of Radical Prostatectomy, Brachytherapy, and External Beam Patients Treated From 2000-2001. Oncology 24(4, S3):50, 4/2010.
22. Ludwig MS, Lev L, Frank SJ, Hoffman K, Lee AK, McGuire SE, Nguyen QN, Choi S, Woodward W, Kuban DA. Influence of Prognostic Factors on Duration of Hormone Therapy and Outcomes. Oncology 24(4, S3):46, 4/2010.
23. Shirvani SM, Kudchadker RJ, Bruno TL, Swanson DA, Frank SJ. Letting the Catheter Out of the Bag: The Effect of Urinary Catheterization on Post-Implant Dosimetry After Prostate Brachytherapy with Palladium-103. Oncology 24(4, S3):49, 4/2010.
24. Sharp HJ, Swanson DA, Zhang M, Phan J, Bruno TL, Kudchadker R, Kuban DA, Lee AK, Choi S, Nguyen Q, Frank SJ. Prostate Brachytherapy Preceded by Screening Colonoscopy Diagnoses Colorectal Cancers in Asymptomatic Patients. Oncology 24(4, S3):46, 4/2010.
25. Frank SJ. Cobalt Chloride Complex Contrast (C4) agent is safe for MRI-based Prostate Brachytherapy: A Toxicokinetic Evaluation of Intraprostatic Administration in a Rat Model. American Radium Society 92nd Annual Meeting, 2010.
26. Frank SJ, Tailor R, Martirosyan K, Stafford J, Swanson D, Sing D, Choi J, Elliot A, Mourtada F, Kudchadker R, Ibbott G. C4 MRI ECAMS have no effect on I see anisotropy and are visibile after radiation exposure. Proceedings from 30th Annual Meeting of the American Brachytherapy Society 8(2), 5/2009.
27. Whaley JT, Levy LB, Swanson DA, Kudchadker RJ, Bruno TL, Frank SJ. Sexual outcomes unaffected by penile bulb dose in prostate brachytherapy. Proceedings from 30th Annual Meeting of the American Brachytherapy Society 8(2), 5/2009.
28. Parker Pa, Latini DM, Ward JF, Pettaway C, Pisters LL, Matin S, Frank SJ, Brown V, Kuban D, Logothetis C, Kim J, Davis JW. Association between uncertainty, anxiety, and quality of life in men with prostate cancer on active surveillance. Society of Behavioral Medicine 37, 4/2009.
29. Morikawa LK, Levy LB, Choi S, Nguyen QN, Cheung MR, Frank SJ, Lee A, Kuban DA. Relationship Between Psa Failure and Death From Prostate Cancer After Radical External Beam Radiation Therapy. Proceedings from ASTRO 2009 Annual Meeting, 2009.
30. Frank SJ, Stafford RJ, Bankson JA, Swanson DA, Kudchadker RJ, Martirosyan KS. A Novel MRI-based Approach to Prostate Brachytherapy. Proceedings from the World Congress of Brachytherapy, 2008.
31. Martirosyan K, Stafford RJ, Bankson J, Frank S. Encapsulated Contrast Agent Marker (ECAM) for MRI Prostate Brachytherapy. Proceedings from The Minerals, Metals and Materials Society 2008 Annual Meeting, 2008.
32. Phan J, Swanson DA, Kuban DA, Lee AK, Cheung R, Choi S, Kudchadker R, Bruno T, Levy LB, and Frank SJ. Long-term rectal complications following permanent prostate brachytherapy at the University of Texas M.D. Anderson Cancer Center. Proceedings from the Radium Society, 2008.
33. Anderson JF, Swanson DA, Kuban DA, Lee AK, Cheung RM, Choi S, Kudchadker T, Bruno T, Levy LB, Frank SJ. Long-term urinary complications following permanent prostate brachytherapy at the University of Texas M.D. Anderson Cancer Center. Proceedings from the Radium Society, 2008.
34. Frank SJ, Fisher C, Levy LB, Kudchadker R, Kuban DA, Lee AK, Cheung RM, Choi S, Bruno TL, Swanson DA. Pre-implant Urinary Symptoms Predict for Worse Urinary Outcomes. Proceedings from ASTRO 2008, 2008.
35. Frank SJ, Kuban DA, Lee AK, Levy LB, Kudchadker R, Bruno T, Swanson DA. Prostate Brachytherapy – The M.D. Anderson Cancer Center Experience. Proceedings from the American Urologic Association (AUA), 2008.
36. Frank SJ, Swanson DA, Kuban DA, Lee AK, Levy LB. Prostogram-predicted brachytherapy outcomes may not be universally accurate: An analysis based on the M. D. Anderson Cancer Center experience with I-125 brachytherapy. Proceeding from the World Congress of Brachytherapy, 2008.
37. Vassiliev ON, Kudchadker RJ, Swanson DA, Kuban DA, Bruno TL, Frank SJ. Systematic Evaluation of Periurethral Stranded Seed Migration and its Dosimetric Consequences in Prostate Brachytherapy. Proceedings from ASTRO 2008, 2008.
38. Frank SJ, Petsuksiri J, Ang KK, Morrison WH, Chao KSC, Rosenthal DI, Schwartz DL, Chronowski G, Weber RS, Garden AS. Intensity Modulated Radiation Therapy for Squamous Cell Carcinoma Metastatic to Cervical Lymph Nodes from an Unknown Primary Site; Outcomes and Patterns of Failure. Proceedings of ASTRO 49th Annual Meeting, 2007.
39. Cheung R, Tucker S, de Crevoisier R, Lee A, Frank SJ, Kudchadker R, Thames , Mohan R, Kuban D. Identification of the Bladder Dose and Volume Constraints to Control Late Urinary Toxicity after External Beam Radiotherapy for Prostate Cancer. ASTRO - 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA. 2006.
40. Kanke JE, Amin MA, Wong P, Ang KK, Garden AS, Morrison WH, Chao KSC, Rosenthal D, Allen P, Frank SJ. Optimizing Head and Neck Radiation Treatment Planning Using an IMRT Monoisocentric Technique with a Static Low Anterior Neck Field. ASTRO - 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA. 2006.
41. Frank SJ, Pisters LL, David J, Lee AK, Cheung R, Swanson D, Bassett RL, Pettaway CA, Kuban DA. Quality of Life after Monotherapy Treatment for Localized Prostate Cancer: Implant (I-125), Radical Prostatectomy, and High Dose External Beam Radiation. ASTRO - 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA. 2006.
42. Petsuksiri J, Frank SJ, Garden AS, Ang KK, Morrison WH, Chao KC, Rosenthal DI, Schwartz DL, Ahamad A, Esmaeli B. Radiation Therapy for Squamous Cell Carcinoma of the Eyelid. ASTRO - 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA. 2006.
43. Frank SJ. 45th Annual Scientific Meeting - ASTRO, Salt Lake City, UT, 2003.
44. Frank SJ. The Implementation of Heterogeneity Corrections for Lung Cancer. Texas Radiological Society (TRS) 90th Annual Scientific Meeting, Woodlands, TX, 2003.
45. Frank SJ. Heterogeneity vs. Homogeneity Corrections for Early Stage NSCLC. RSNA - Radiological Society of North America, Chicago, IL, 89th Annual Scientific Meeting, 2002.
46. Frank SJ. Treatment Planning with Heterogeneity Corrections for Stage I/II Lung Cancer. Fletcher Society Annual Scientific Meeting, Las Vegas, NV, 2002.
47. Frank SJ. Definitive Treatment of Vaginal Cancer with Radiation Therapy: The MD Anderson Cancer Center (MDACC) Experience. 1970 -2000, 2000.

Grant & Contract Support

Title: An innovative MRI-based approach to improve cure rates and quality of life with prostate brachytherapy
Funding Source: MDACC (TRC)
Role: Principal Investigator-MDACC
Duration: 2/1/2010 - 12/31/2010
 
Title: Seeds and Markers for MRI-based Treatment
Funding Source: Texas Ignition Fund
Role: Principal Investigator
Duration: 8/1/2009 - 12/31/2010
 
Title: Head and Neck Paranasal Sinus Cancer Clinical Project
Funding Source: NIH/NCI
Role: Co-Principal Investigator
Principal Investigator: Delaney Thomas
Duration: 9/1/2008 - 8/31/2013
 
Title: An innovative MRI-based approach to improve cure rates and quality of life in prostate brachytherapy (Matching Grant)
Funding Source: Prostate Cancer Foundation
Role: Principal Investigator
Duration: 9/1/2008 - 8/31/2011
 
Title: An in-vivo evaluation of C4 for prostate brachytherapy
Funding Source: MDACC (TRC)
Role: Principal Investigator
Duration: 9/1/2008 - 8/31/2010
 
Title: An MRI-based approach to prostate brachytherapy
Funding Source: MDACC (TRC)
Role: Principal Investigator
Duration: 9/1/2007 - 8/31/2008

Last updated: 9/16/2011